Okada Shuichi

オカダシュウイチ | Okada Shuichi

Research field (1)： Metabolism and endocrinology

Research keywords (7)：インスリン分泌細胞の分化・誘導 , 脂肪分化 , インスリン抵抗性 , インスリンシグナル , Adipogenesis , Insulin resistance , Insulin signal

MISC (225)：

Takuya Watanabe, Atsushi Ozawa, Sumiyasu Ishii, Takuya Tomaru, Nobuyuki Shibusawa, Tsugumichi Saito, Eijiro Yamada, Kazuhiko Horiguchi, Yasuyo Nakajima, Shunichi Matsumoto, et al. Usage of continuous glucose monitoring (CGM) for detecting an unrecognized hypoglycemia and management of glucocorticoid replacement therapy in adult patients with central hypoadrenalism. Endocrine journal. 2018. 65. 5. 547-556
Takuya Watanabe, Atsushi Ozawa, Sumiyasu Ishii, Takuya Tomaru, Nobuyuki Shibusawa, Tsugumichi Saito, Eijiro Yamada, Kazuhiko Horiguchi, Yasuyo Nakajima, Shunichi Matsumoto, et al. Usage of continuous glucose monitoring (CGM) for detecting an unrecognized hypoglycemia and management of glucocorticoid replacement therapy in adult patients with central hypoadrenalism. Endocrine journal. 2018. 65. 5. 547-556
Junichi Okada, Shunichi Matsumoto, Kyoichi Kaira, Tsugumichi Saito, Eijiro Yamada, Hideaki Yokoo, Ryuji Katoh, Motoyasu Kusano, Shuichi Okada, Masanobu Yamada. Sodium Glucose Cotransporter 2 Inhibition Combined With Cetuximab Significantly Reduced Tumor Size and Carcinoembryonic Antigen Level in Colon Cancer Metastatic to Liver. Clinical colorectal cancer. 2018. 17. 1. e45-e48
Junichi Okada, Shunichi Matsumoto, Kyoichi Kaira, Tsugumichi Saito, Eijiro Yamada, Hideaki Yokoo, Ryuji Katoh, Motoyasu Kusano, Shuichi Okada, Masanobu Yamada. Sodium Glucose Cotransporter 2 Inhibition Combined With Cetuximab Significantly Reduced Tumor Size and Carcinoembryonic Antigen Level in Colon Cancer Metastatic to Liver. Clinical colorectal cancer. 2018. 17. 1. e45-e48
Takashi Okamura, Yasuyo Nakajima, Nobuyuki Shibusawa, Kazuhiko Horiguchi, Shunichi Matsumoto, Eijiro Yamada, Takuya Tomaru, Sumiyasu Ishii, Atsushi Ozawa, Takahiro Ishizuka, et al. Pituitary NR4A1 is negatively regulated by thyroid hormone without direct binding of thyroid hormone receptors on the gene. Molecular and cellular endocrinology. 2018. 461. C. 32-42

ｍore...

Patents (1)：

FAM83Gタンパク質又はその部分ペプチドを用いたHSP27リン酸化阻害剤、アポトーシス誘導剤および抗癌剤

Lectures and oral presentations (117)：

Syntaxin4 binding molecules and insulin resistance.
(PepCon-2017 2017)
Syntaxin4 binding molecules and insulin resistance.
(PepCon-2017 2017)
FAM83G is a novel apoptosis inducer.
(Experimental Biology 2016)
FAM83G is a novel apoptosis inducer.
(Experimental Biology 2016)
Synip phosphorylation is necessary for insulin-stimulated Glut4 translocation and glucose uptake in podocyte.
(75th Scientific sessions 2015)

ｍore...

Education (2)：

- 1983 Niigata University Faculty of Medicine School of Medicine
- 1983 Niigata?niversity Faculty?f?edicine

Professional career (1)：

条件付必須項目の入力がありません (Gunma?niversity)

Work history (8)：

2003 - 2003 Stoney Brook University (Vititing assistant professor)
2003 - 2003 Stoney Brook University (Vititing assistant professor)
2001 - 2001 University of Florida (Visiting assistant professor)
2001 - 2001 University of Florida (Visiting assistant professor)
1994 - 1999 University Iowa (IA, USA)、Senior postdoctoral fellow

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page